Firefly Neuroscience is trading 7.31% down at $1.01 after closing at $1.09 on August 18, 2026, with no credible company-specific announcement dated August 19, 2026 identified.
- Recent company news included a 291% increase in TMS-center brain-scan volumes on August 5; shareholder-approved capital-structure changes were reported earlier in August.
- Broader futures are only modestly mixed, so the pre-market decline cannot be confidently attributed to marketwide weakness.